Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Ending Cash Position : ¥222.4 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Shengda Bio-Pharm Co Ending Cash Position?

Zhejiang Shengda Bio-Pharm Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ¥222.4 Mil.

Zhejiang Shengda Bio-Pharm Co's quarterly Ending Cash Position increased from Sep. 2024 (¥145.5 Mil) to Dec. 2024 (¥263.5 Mil) but then declined from Dec. 2024 (¥263.5 Mil) to Mar. 2025 (¥222.4 Mil).

Zhejiang Shengda Bio-Pharm Co's annual Ending Cash Position increased from Dec. 2022 (¥303.4 Mil) to Dec. 2023 (¥305.9 Mil) but then declined from Dec. 2023 (¥305.9 Mil) to Dec. 2024 (¥263.5 Mil).

Zhejiang Shengda Bio-Pharm Co Ending Cash Position Historical Data

The historical data trend for Zhejiang Shengda Bio-Pharm Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shengda Bio-Pharm Co Ending Cash Position Chart

Zhejiang Shengda Bio-Pharm Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

442.40

490.02

303.36

305.87

263.51

Zhejiang Shengda Bio-Pharm Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															247.28	212.87	145.55	263.51	222.37

Zhejiang Shengda Bio-Pharm Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Zhejiang Shengda Bio-Pharm Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	305.869	+	-42.36
	=	263.5

Zhejiang Shengda Bio-Pharm Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	263.508	+	-41.142
	=	222.4

Zhejiang Shengda Bio-Pharm Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Zhejiang Shengda Bio-Pharm Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Shengda Bio-Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shengda Bio-Pharm Co Ltd (SHSE:603079) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No.789, Renmin East Road, Chicheng Street, Tiantai County, Zhejiang Province, Hangzhou, CHN, 317200

Website

http://www.sd-pharm.com

Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid and other vitamin products, as well as nisin and natamycin.

Executives

Pang Ai Ming	Director
Zhu Yong Gang	Director

Zhejiang Shengda Bio-Pharm Co Headlines

No Headlines